Unique IDiCARE-RD-0048
Prefix / Honorific (optional) (Prefix)Dr.
First or given name (First name)Rubee
Last or family name (Last name)Dev
Email (Enter your email)rubee@ualberta.ca
Other investigators or team members (optional)Teresa Gisinger, Rubee Dev, Alexander Kautzky, Jürgen Harreiter, Valeria Raparelli, Karolina Kublickiene, Maria Trinidad Herrero, Colleen M. Norris, Louise Pilote, Alexandra Kautzky-Willer
InstitutionUniversity of Alberta
Country (Country)Canada
Analysis Plan TitleSex and Gender Impact Mental and Emotional Well-Being during COVID-19
Analysis Plan DescriptionThe relationship between the biological sex and emotions and behavior during the pandemic as well as adhering to safety measures will be assessed with a logistic regression model. Next the relationship between gender-related variables and the emotions and mental health will be assessed in the general, female and male cohorts with logistic regressions. The outcomes of interest are the emotions and mental health, more specifically: “feeling nervous, anxious and worried”, feeling sad, depressed and hopeless”, “feeling irritable, frustrated and angry”, “feeling lonely and isolated”, having more physical fights and arguments with family members and working more during the COVID-19 pandemic.  For the analyses, we will transform the outcome variables into binominal variables. The response ‘extremely’ and ‘somewhat likely’ where defined as a positive response. ‘Unlikely’ or ‘very unlikely’ will be defined as a negative response concerning the question. Logistic regression models will be computed respectively for every emotion as outcome variable and with main effects of biological sex, educational level, work status, income level and number of children in the household. These models will be adjusted for age.
Keyword 1COVID-19
Keyword 2Mental health
Keyword 3 (optional)Gender medicine
Keyword 4 (optional)Safety measures
Convenience dataConvenience data
Location dataGlobal
Data Time FrameData from specific surveys
Data Time Frame – Specific Survey (Convenience)Survey 1 – March 27 to May 5, 2020, Survey 2 – May 6 to June 7, 2020, Survey 3 – June 8 to July 21, 2020, Survey 4 – July 22 to September 15, 2020, Survey 5 – September 16 to November 1, 2020, Survey 6 – November 2 to December 13, 2020, Survey 7 – December 14, 2020 to February 8, 2021
Target completion date (optional)30-12-2022
Entry Date11-04-2022 19:57
Latest update2022-05-26: Closed, paper has been accepted by BMJ Open